Cardiotoxicity among socioeconomically marginalized breast cancer patients.

Yan LuAaron W GehrIfedioranma AnikpoRachel J MeadowsKevin J CratenKalyani NarraAnuradha LingamSandeep KamathBhavna TannaBassam GhabachRohit P Ojha

Published in: Breast cancer research and treatment (2022)

Our findings suggest high risk of cardiotoxicity among socioeconomically marginalized breast cancer patients after initiation of anthracyclines or trastuzumab. Strategies are needed for optimizing cancer treatment effectiveness while minimizing cardiotoxicity in this population.

Keyphrases

randomized controlled trial
systematic review
epidermal growth factor receptor
metastatic breast cancer
tyrosine kinase